Its misregulation can lead to pigmentation disorders, such as urticaria pigmentosa and age-related skin changes (Gonçalves et al. 2017), making tyrosinase inhibition a promising strategy to reduce melanin overproduction. This evidence concerns the gene TYR and maculopapular cutaneous mastocytosis.